Simplex Trading’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,100
Closed -$11K 9952
2024
Q4
$11K Sell
1,100
-300
-21% -$2.9K ﹤0.01% 7160
2024
Q3
$13K Buy
1,400
+200
+17% +$1.73K ﹤0.01% 7039
2024
Q2
$10K Buy
+1,200
New +$11K ﹤0.01% 7464
2024
Q1
Sell
-3,400
Closed -$32K 10139
2023
Q4
$32K Sell
3,400
-26,400
-89% -$247K ﹤0.01% 6519
2023
Q3
$267K Buy
29,800
+8,200
+38% +$77.9K ﹤0.01% 4055
2023
Q2
$242K Buy
+21,600
New +$192K ﹤0.01% 4083
2022
Q4
Sell
-100
Closed -$1K 10694
2022
Q3
$1K Buy
+100
New +$1.22K ﹤0.01% 9699

Other funds holding ENFN

Simplex Trading's ENFN Position: Q2 2025 in Review

Simplex Trading sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 200 shares — an estimated $2K sold.

Simplex Trading first reported a position in ENFN in Q2 2022 and held it in 3 quarters. The position peaked at $340K in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Simplex Trading reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 200 Enfusion, Inc. shares in Q2 2025, an estimated $2K.
  • Simplex Trading first reported a position in Enfusion, Inc. in Q2 2022 and held it in 3 quarters.
  • Simplex Trading's Enfusion, Inc. position peaked at $340K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.